TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...

Ensitrelvir cut household contacts' risk of developing COVID by more than half ...

The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.

By Julie Steenhuysen CHICAGO, June 1 (Reuters) - Merck is in discussions with various global health authorities about making ...

The U.S. FDA has approved ensitrelvir (Xocova), an oral antiviral developed by Shionogi, to help prevent COVID-19 in ...

An at-home pill against coronavirus halves the chance that people newly diagnosed with COVID-19 will land in the hospital or ...

As governments and health authorities rush to meet the moment of a worsening Ebola outbreak in central Africa, Merck & Co. is considering dusting off its antiviral molnupiravir, which saw use as a ...

An illustration shows a molecule nestled inside a large lumpy green mass. According to researchers' predictions, the antiviral candidate, venetoclax (red and purple), could limit SARS-CoV-2's ability ...

BEIJING--When Li’s 83-year-old father with diabetes started coughing and complaining of body aches last month, the Beijing ...

This fall’s updated COVID-19 vaccines should target the SARS-CoV-2 XFG variant, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) said ...

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the ...

In a major expansion of the pandemic treatment toolkit, the U.S. Food and Drug Administration (FDA) has officially approved ...